Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 16Neoplasms 4Neoplasm Metastasis 4Prostatic Neoplasms 3Multiple Myeloma 3Giant Cell Tumor of Bone 3Carcinoma, Renal Cell 3Smoldering Multiple Myeloma 2Recurrence 2Osteoporosis 2Melanoma 2Kidney Neoplasms 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Cancer Metastatic 1Parathyroid Neoplasms 1Osteoporotic Fractures 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplastic Cells, Circulating 1Musculoskeletal Pain 1Mastocytosis, Systemic 1Lung Neoplasms 1Inflammatory Breast Neoplasms 1Hyperparathyroidism, Primary 1Granuloma, Giant Cell 1Giant Cell Tumors 1

Interventions

Denosumab 2X-Rays 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Bone Cysts, Aneurysmal × Denosumab × Clear all
NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Leiden University Medical Center

Phase 2 Unknown
60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

NCT03415477 2018-01-30

Deno-ABC

Peking University People's Hospital

Phase 1/2 Completed
6 enrolled

Fractures, Spontaneous, Neoplasms, Recurrence, Bone Cysts, Aneurysmal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡